PARP1 and glioblastoma: PARP inhibitors have demonstrated their effectiveness in eliminating GBM (glioblastoma multiforme) cells both in laboratory settings (in vitro) and in live organisms (in vivo), either when used alone or in combination with chemo-radiation.